抑郁与接受TAVR或SAVR的老年人死亡率相关
该研究基于FRAILTY-AVR前瞻性队列,纳入3国14中心1035例70岁以上接受TAVR或SAVR的老年人,用老年抑郁量表短表评估抑郁。基线抑郁筛查阳性者占31.5%,仅8.6%有临床记录。校正混杂因素后,基线抑郁与1个月和12个月死亡率相关,持续性抑郁与12个月死亡率约3倍增加相关。
要点
- TAVR或SAVR老年患者中约1/3基线抑郁筛查阳性,但临床记录仅8.6%。
- 基线抑郁与术后1个月和12个月全因死亡率升高独立相关。
- 术后6个月仍存在的持续性抑郁与12个月死亡率约3倍增加相关。
核心结论
- 在接受TAVR或SAVR的70岁以上老年人中,约三分之一存在基线抑郁症状,且与短期和中期全因死亡率升高相关。
- 随访时持续性抑郁症状的患者死亡风险最高。
研究设计与样本
- FRAILTY-AVR前瞻性队列研究的预先计划分析,纳入3个国家14个中心,2011年11月15日至2016年4月7日。
- 共纳入1035例70岁及以上接受TAVR或SAVR的老年人,平均(SD)年龄81.4(6.1)岁,男性427例(41.3%),女性608例(58.7%)。
- 基线及随访时使用老年抑郁量表短表评估抑郁症状。
主要发现
- 326例(31.5%)基线抑郁筛查阳性,仅89例(8.6%)临床记录有抑郁。
- 校正临床和老年综合混杂因素后,基线抑郁与1个月死亡率相关(OR 2.20;95%CI 1.18-4.10)。
- 基线抑郁与12个月死亡率相关(OR 1.532;95%CI 1.03-2.24)。
- 持续性抑郁(术后6个月仍存在基线抑郁)与12个月死亡率约3倍增加相关(OR 2.98;95%CI 1.08-8.20)。
临床怎么用
- 对接受TAVR或SAVR的老年患者,应常规进行抑郁筛查,因临床记录明显低估抑郁。
- 识别基线抑郁及持续性抑郁患者,可能有助于风险分层和加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression is increasingly recognized as a risk factor for adverse outcomes in cardiovascular disease. However, little is known about depression in older adults undergoing transcatheter (TAVR) or surgical (SAVR) aortic valve replacement. OBJECTIVE: To determine the prevalence of depression and its association with all-cause mortality in older adults undergoing TAVR or SAVR. DESIGN, SETTING, AND PARTICIPANTS: This preplanned analysis of the Frailty Aortic Valve Replacement (FRAILTY-AVR) prospective cohort study included 14 centers in 3 countries from November 15, 2011, through April 7, 2016. Individuals 70 years or older who underwent TAVR or SAVR were enrolled. Depressive symptoms were evaluated using the Geriatric Depression Scale Short Form at baseline and follow-up. MAIN OUTCOMES AND MEASURES: All-cause mortality at 1 and 12 months after TAVR or SAVR. Logistic regression was used to determine the association of depression with mortality after adjusting for confounders such as frailty and cognitive impairment. RESULTS: Among 1035 older adults (427 men [41.3%] and 608 women [58.7%]) with a mean (SD) age of 81.4 (6.1) years, 326 (31.5%) had a positive result of screening for depression, whereas only 89 (8.6%) had depression documented in their clinical record. After adjusting for clinical and geriatric confounders, baseline depression was found to be associated with mortality at 1 month (odds ratio [OR], 2.20; 95% CI, 1.18-4.10) and at 12 months (OR, 1.532; 95% CI, 1.03-2.24). Persistent depression, defined as baseline depression that was still present 6 months after the procedure, was associated with a 3-fold increase in mortality at 12 months (OR, 2.98; 95% CI, 1.08-8.20). CONCLUSIONS AND RELEVANCE: One in 3 older adults undergoing TAVR or SAVR had depressive symptoms at baseline and a higher risk of short-term and midterm mortality. Patients with persistent depressive symptoms at follow-up had the highest risk of mortality.
引用
- Drudi LM, Ades M, Turkdogan S, et al. Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement. JAMA Cardiol. 2018. PMID: 29344620. doi:10.1001/jamacardio.2017.5064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。